EAM
NUVA

Exos Asset Management’s NuVasive, Inc. NUVA Stock Holding History

Exos Asset Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,348
Closed -$91K – 776
2021
Q2 		$91K Buy
+1,348
New +$92K 0.05% 352

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Exos Asset Management's NUVA Position: Q3 2021 in Review

Exos Asset Management sold out of NuVasive, Inc. (NUVA) in Q3 2021, closing a stake of 1,348 shares — an estimated $91K sold.

Exos Asset Management first reported a position in NUVA in Q2 2021 and held it in 1 quarter. The position peaked at $91K in Q2 2021. 250 funds tracked by Wall St. Rank hold NUVA as of Q3 2021.

  • Exos Asset Management reported no remaining NuVasive, Inc. position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 1,348 NuVasive, Inc. shares in Q3 2021, an estimated $91K.
  • Exos Asset Management first reported a position in NuVasive, Inc. in Q2 2021 and held it in 1 quarter.
  • Exos Asset Management's NuVasive, Inc. position peaked at $91K in Q2 2021.
  • 250 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.